Clinical trials
Phase 2 Triple Negative Breast Neoplasms trials in Spain
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
27 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 4 |
| 2013 | 1 |
| 2015 | 1 |
| 2017 | 4 |
| 2018 | 2 |
| 2019 | 3 |
| 2020 | 5 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 13 |
| Terminated | 10 |
| Active, not recruiting | 3 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| MedSIR | 4 |
| Merck Sharp & Dohme LLC | 3 |
| Novartis Pharmaceuticals | 3 |
| SOLTI Breast Cancer Research Group | 3 |
| AVEO Pharmaceuticals, Inc. | 1 |
| AstraZeneca | 1 |
| Ayala Pharmaceuticals, Inc, | 1 |
| BerGenBio ASA | 1 |
| Celldex Therapeutics | 1 |
| CytomX Therapeutics | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Triple Negative Breast Neoplasms | 27 |
| Breast Neoplasms | 14 |
| Stomach Neoplasms | 3 |
| Carcinoma, Hepatocellular | 2 |
| Carcinoma, Renal Cell | 2 |
| Cholangiocarcinoma | 2 |
| Melanoma | 2 |
| Ovarian Neoplasms | 2 |
| Pancreatic Neoplasms | 2 |
| Squamous Cell Carcinoma of Head and Neck | 2 |
Trials
Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.